Kla Quick Ratio (KLAC) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Kla Corporation  (NASDAQ: KLAC)

Kla's Quick Ratio

KLAC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the first quarter 2026, Quick Ratio fell to 1.03 below Kla Corporation average.

Within Scientific & Technical Instruments industry 8 other companies have achieved higher Quick Ratio than Kla in first quarter 2026. While Quick Ratio total ranking in the first quarter 2026 has deteriorated compared to the prior quarter from 2170 to 2732.

Explain Quick Ratio?
How much Cash & cash equivalents KLAC´s has?
What are KLAC´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/KLAC/financial-strength
https://api.csimarket.com/api/v1/companies/KLAC/fundamentals
https://api.csimarket.com/api/v1/companies/KLAC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
KLAC Quick Ratio (Sep 30 2026)
Q1
(Jun 30 2026)
Q4
(Mar 31 2026)
Q3
(Dec 31 2025)
Q2
(Sep 30 2025)
Q1
Y / Y Current Liabilities Change 12.47 %
Y / Y Cash & cash equivalent Change 141.9 %
Quick Ratio MRQ 1.03
KLAC's Total Ranking # 2732
Seq. Current Liabilities Change 5.81 %
Seq. Cash & cash equivalent Change -3.04 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Scientific & Technical Instruments Industry # 9
Technology Sector # 290
Overall Market # 1952


Quick Ratio Statistics
High Average Low
35.2 2.55 0
(Dec 31 2015)   (Jun 30 2015)




Financial Statements
Kla's Current Liabilities $ 4,555 Millions Visit KLAC's Balance sheet
Kla's Cash & cash equivalent $ 4,708 Millions Visit KLAC's Balance sheet
Source of KLAC's Sales Visit KLAC's Sales by Geography


Cumulative Kla's Quick Ratio

KLAC's Quick Ratio for the trailling 12 Months

KLAC Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 2.49 %
Y / Y Cash & cash equivalent TTM Growth 71.45 %
Quick Ratio TTM 1
Total Ranking TTM # 2005
Seq. Current Liabilities TTM Growth 3.14 %
Seq. Cash & cash equivalent TTM Growth 20.04 %


On the trailing twelve months basis KLAC Cash & cash equivalent more than doubled by 141.9 % in Q1 2026 year on year, faster than Current Liabilities, this led to increase in in Kla's Quick Ratio to 1, Quick Ratio remained below KLAC average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Scientific & Technical Instruments industry 14 other companies have achieved higher Quick Ratio than Kla. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending fourth quarter 2026 at 4051.

Explain Quick Ratio?
How much Cash & cash equivalents KLAC´s has?
What are KLAC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Scientific & Technical Instruments Industry # 15
Technology Sector # 618
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
24319.65 403.02 0.42
(Jun 30 2015)   (Dec 31 2024)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Scientific & Technical Instruments Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Mirion Technologies Inc   1.36 $ 408.700  Millions$ 299.800  Millions
Kla Corporation  1.03 $ 4,707.902  Millions$ 4,555.086  Millions
Thermo Fisher Scientific Inc   0.47 $ 6,661.000  Millions$ 14,170.000  Millions

Date modified: 2026-10-30T13:14:34+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.